Drug Discovery & Pharmaceuticals

RSS

Ziath launches new YouTube channel to share its expertise with laboratories

Ziath is launching a new YouTube channel that will house informative videos previewing the latest innovations in the field of drug discovery and bio-banking sample management for the first time as the company seeks to share its expertise and knowledge with laboratories worldwide.

From Ziath Ltd 16 Aug 2019

Scientists take first step towards digital map of the ion channels in the brain

Researchers have mapped the molecular workings of voltage-gated potassium ion channels within the brain.

16 Aug 2019

Thermo Fisher Scientific unveils new Krios solution at Microscopy and Microanalysis 2019

Today at Microscopy and Microanalysis 2019, Thermo Fisher Scientific unveiled a new Krios solution designed to break down the barriers to cryo-EM adoption through improved ease-of-use, faster results and the most compact 300kV cryo-EM microscope design on the market.

From Thermo Fisher Scientific – Electron Microscopy Solutions 6 Aug 2019

Sanofi exercises option to advance innovative Bispecific Small Molecule project

Exscientia, the world-leading Artificial Intelligence (AI)-driven drug discovery company, today announced that Sanofi has exercised its option to progress an innovative Bispecific Small molecule project it discovered as part of its new modality collaboration.

From Sanofi 6 Aug 2019

New antibiotics on the horizon as scientists discover a weakness in the cell wall of pathogenic bacteria

Researchers have discovered a weak spot in the cell wall of pathogenic bacteria that could lead to the development of new antibiotics.

1 Aug 2019

Selective antibiotics could make precision treatment possible

With multi-resistant germs becoming more and more of a threat, we are in need of new antibiotics now more than ever.

31 Jul 2019

IONTAS and Teva Pharmaceuticals announce new antibody optimization agreement

IONTAS Limited, a leader in antibody discovery and optimization of human monoclonal antibody libraries, today announced an agreement with Teva Pharmaceuticals (Teva) to apply its technologies and know-how to the optimization of human antibodies for use as biotherapeutics.

From FairJourney Biologics 31 Jul 2019

Data Integrity in the Pharmaceutical Industry

There have been clear statements from regulatory bodies that have increased the pressure on pharmaceutical companies to go electronic with their records and ensure a high level of data integrity in all areas of the pharmaceutical industry.

From Mettler-Toledo International Inc. 29 Jul 2019

Researchers harness the pain-relieving properties of cannabis to develop new pain killers

The cannabis plant produces pain-relieving molecules that are 30x more effective than aspirin. Researchers are now working on a plant-based pain killer.

25 Jul 2019

Challenging the Glo-Germ Technique for Aerosol Containment During Cell Sorting

Researchers have developed a robust alternative to the glo-germ assay to determine cell sorter aerosol containment that is rapid, accurate and efficient.

25 Jul 2019

High-resolution images offer clues to improve design of anti-nausea drugs

A new study using a special type of electron microscope using samples cooled to extremely cold temperatures provides critical information for drug developers seeking to reduce nausea and vomiting side effects of cancer treatments.

23 Jul 2019

Servier chooses Pall as single-source supplier for new biomanufacturing facility

Pall Corporation, a global leader in filtration, separation and purification, has been chosen by Servier, an independent international pharmaceutical company, as an exclusive technology and services provider for their Gidy, France biomanufacturing facility.

From Pall Corporation 22 Jul 2019

BIA Separations selected to support AveXis’ gene therapy pipeline

BIA Separations, a leading biochromatography development and manufacturing company, today announced it is collaborating with AveXis, a Novartis company, to enhance the commercial purification process for its gene therapy pipeline, beginning with Zolgensma (onasemnogene abeparvovec-xioi), the first U.S. Food and Drug Administration-approved gene therapy indicated for the treatment of pediatric patients with spinal muscular atrophy (SMA) who are less than two years of age.

22 Jul 2019